Recent Updates — NNOX
Nano-X Imaging Ltd. has filed a proxy statement for a special general meeting on November 18, 2026, to vote on two proposals. First, shareholders will approve an amendment to the articles of association to increase authorized share capital by NIS 3,000,000 (300 million shares), raising total authorization to 450 million shares. Second, shareholders will approve a framework allowing the board to effect a reverse split at a ratio between 1-for-20 and 1-for-50 within 18 months. The company cites Nasdaq’s $1.00 minimum bid price non-compliance notification received on September 28, 2026, as the primary driver for the split framework to avoid potential delisting by March 29, 2027. Nano-X Imaging Ltd. operates in the healthcare imaging and health information technology industries.
Guy Nathansohn stepped down as Chief Financial Officer of Nano-X Imaging Ltd on October 26, 2026, due to medical reasons. The resignation was not caused by any disagreement with the company regarding operations or policies. The firm has initiated a search for a replacement CFO. Nano-X Imaging Ltd develops and manufactures portable digital X-ray systems for the healthcare industry.
Nano-X Imaging reported preliminary unaudited third-quarter revenue of approximately $4.3 million to $4.4 million for the period ended September 30, 2026, up from $3.4 million in the prior-year quarter. Revenue growth was driven by a surge in AI and software solutions to $1.0 million, following the consolidation of Nanox Health IT Inc., while teleradiology revenue remained flat at $3.1 million. The company’s cash position declined significantly to approximately $26.0 million from $60.0 million at year-end 2025. Management stated that current liquidity is insufficient to support operations for the next twelve months, raising substantial doubt about its ability to continue as a going concern and noting potential risks to product development or commercialization efforts if additional capital cannot be raised. Nano-X Imaging Ltd. operates in the medical imaging technology sector, providing integrated hardware, AI-based diagnostic solutions, and teleradiology services.
Nanox Imaging received a notice from Nasdaq on September 28, 2026, indicating non-compliance with the minimum bid price requirement due to shares closing below $1.00 for 30 consecutive business days. The company has an initial compliance period until March 29, 2027, to restore the share price to at least $1.00 for ten consecutive trading days. Failure to comply may result in a transfer to the Nasdaq Capital Market or further delisting proceedings. Nanox Imaging operates in the medical technology industry, providing digital X-ray imaging solutions.